Cohort comprises six startups in solutions like Oncology, Cardiology, Genomics, and Remote Patient Monitoring from across India and Singapore
Bengaluru, NFAPost: Recognising the emergent need for next-generation technologies and diagnostic solutions in Oncology, Cardiology, Genomics and Remote Patient Monitoring, GE Healthcare’s India Edison™ Accelerator has announced its Cohort 3 comprising of six start-up companies from these areas.
Based out of India and Singapore, these companies- 4basecare, Haystack Analytics, zMed Healthcare Technologies, Tricog, AIRA Matrix and Qritive – will spend six months with healthcare industry experts from within and outside GE who will help them build and scale up their solutions for new market segments.
GE Healthcare South Asia VP, Engineering Girish Raghavan said at the India Edison Accelerator GC collaborates with innovators to develop technologies that facilitate access while improving operational efficiency and clinical outcomes.
“In the post-pandemic phase, as the healthcare industry relies increasingly on technology to bridge gaps in patient care we are excited to welcome six high-tech start-ups to our Accelerator. Over the next six months, they will work alongside GE’s healthcare engineers and scientists to make their healthcare solutions accessible to more communities around the world,” said Girish Raghavan.
GE Healthcare – India & South Asia region President & CEO Wipro GE Healthcare and Managing Director Dr. Shravan Subramanyam said GE Healthcare continues to strengthen its portfolio in clinical care areas like Cardiology and Oncology while expanding expertise into Virtual Care and Remote Patient Monitoring.
“The Edison platform is at the core of GE Healthcare’s strategy. It has helped us accelerate innovations. The start-ups in Cohort 3 have smart artificial intelligence and machine learning solutions. When integrated with the Edison platform, these solutions can scale up to help doctors, clinicians, care professionals and ultimately patients,” said Dr. Shravan Subramanyam.
Applications from start-ups for Cohort 3 were shortlisted using evaluation criteria such as the strength of the business idea, maturity of product and team capabilities, among others. The India Edison Accelerator provides start-ups with mentorship, skill development programs, commercial and regulatory guidance as well as data provisioning.
About the six start-ups in 3rd Cohort:
1. 4basecare: Through unique patient-centric solutions in Genomics and Digital Health, 4basecare is building the largest resource of comprehensive, longitudinal clinic-genomics data of cancer patients from Asia. https://4basecare.com/
2. Haystack Analytics: Enables simplifying complex genomic analysis for a better clinical decision in terms of comprehensive and accurate diagnosis. https://haystackanalytics.in/
3. zMed Healthcare Technologies: Provides comprehensive clinical data integration and advanced clinical AI for predicting clinical events and supporting all inpatient units of the hospital from the ICU to an Emergency Unit. https://zmed.tech/
4. Tricog: Makes virtual cardiology services available to remote clinics via AI and machine learning algorithms. https://www.tricog.com/
5. AIRA Matrix: Provides AI-based solutions to automate image and data analysis in drug discovery/ development and healthcare. https://www.airamatrix.com/
6. Qritive: CE marked digital pathology platform and AI help pathology labs cater to more patients at a substantially higher quality. https://www.qritive.com/
The India Edison Accelerator’s Cohort 2 graduated in June 2021. It included six promising health-tech start-ups – Aarogya AI, Brain Sight AI, InMed Prognostics, Onward Assist, Fluid AI and Wellthy Therapeutics. These companies continue to engage with the India Edison Accelerator in the areas of market expansion and technology.
GE Healthcare unveiled the India EdisonTM Accelerator in August 2019 with a focus on nurturing the start-up ecosystem. Start-ups collaborate with GE Healthcare to arrive at solutions that improve patient outcomes and experience, efficiency of clinical practices and that of the healthcare facilities, reduce waste and inefficiencies, and eliminate costly and harmful errors. For more information on the program, visit: start-ups.gehc.co. You can follow the program on Twitter @GEHCI_Xlerator
The Edison platform is an advanced intelligence offering used by GE Healthcare’s internal developers and strategic partners to develop new healthcare applications, services and AI algorithms. It comprises applications, smart devices and a cloud-based platform. There are over 100 applications currently available on the Edison platform.
GE Healthcare is the $16.7 billion healthcare business of GE (NYSE: GE). As a leading global medical technology and digital solutions innovator, GE Healthcare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.
With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.
In India, GE Healthcare operates in a JV (Wipro GE Healthcare WGE)) with Wipro Limited. WGE is focused on some of the country’s toughest healthcare challenges– lowering maternal and infant deaths, enabling early detection of cancer and addressing heart diseases early.
WGE pioneered innovation of healthcare imaging technologies ‘In India for India and the world’ to enhance access to quality healthcare at affordable costs to more people.
